Target intelligence / Profile preview

Ribosomal protein L12 pseudogene 43 (RPL12P43)

Target: RPL12P43
Molecular classification: Other, pseudogene, processed pseudogene

Overview

Ribosomal protein L12 pseudogene 43 (RPL12P43) is a processed pseudogene in humans, sharing sequence similarity with the functional RPL12 gene that encodes a constituent of the 60S ribosomal subunit[8][5]. As a pseudogene, RPL12P43 is not translated into a functional protein and is not known to play a direct role in cellular physiology, therapeutic targeting, or disease. The gene is annotated in genome databases but lacks biological, pharmacological, or clinical significance.

Other names: RPL12_24_1805RPL12P43

Beyond the preview

Go deeper on Ribosomal protein L12 pseudogene 43 (RPL12P43).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L12 pseudogene 43 (RPL12P43).

Explore the full profile